-- High cost of drugs to treat people with endocrine disorders
-- Prior-authorization programs under Medicare Part C and Medicare Fee for Service
-- S. 283 / H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019: To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement
-- Coverage for innovative diabetes technology
Duration: February 9, 2009
to
March 18, 2019
General Issues: Health Issues , Medicare/Medicaid
Spending: about $920,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), U.S. Senate,, Centers For Medicare and Medicaid Services (CMS), Agriculture - Dept of (USDA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2019
Galileo Consulting Group, Inc. terminated an engagement in which they represented American Association of Clinical Endocrinologists on July 22, 2019.
Original Filing: 301058880.xml
Lobbying Issues
-- High cost of drugs to treat people with endocrine disorders
-- Prior-authorization programs under Medicare Part C and Medicare Fee for Service
-- S. 283 / H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019: To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- Coverage for innovative diabetes technology
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on April 22, 2019.
Original Filing: 301037869.xml
Lobbying Issues
-- High cost of drugs to treat people with endocrine disorders
-- Prior-authorization programs under Medicare Part C and Medicare Fee for Service
-- S. 283: Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019 - To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- Coverage for innovative diabetes technology
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on Jan. 22, 2019.
Original Filing: 301016971.xml
Lobbying Issues
-- High cost of drugs treat people with endocrine disorders
-- Prior-authorization programs under Medicare Part and Medicare Fee for Service
-- S. 3160 / H.R. 1898 - To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under Part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement
-- S. 830 / H.R. 1953 - Treat and Reduce Obesity Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- CY 2019 Proposed Medicare Physician Fee Schedule - Proposal regarding Office Visit documentation and payments; congressional letters to Centers for Medicare and Medicaid Services.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on Oct. 19, 2018.
Original Filing: 300992536.xml
Lobbying Issues
-- High cost of drugs treat people with endocrine disorders
-- H.R. 1898 / S. 3160 - To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement
-- H.R. 1953 / S. 830 - Treat and Reduce Obesity Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- CY 2019 Proposed Medicare Physician Fee Schedule - Proposal regarding office visit documentation and payments; congressional letters to Centers for Medicare and Medicaid Services.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on July 20, 2018.
Original Filing: 300975216.xml
Lobbying Issues
-- High cost of drugs treat people with endocrine disorders
-- H.R. 1898 / S. 3160 - To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement
-- H.R. 1953 / S. 830 - Treat and Reduce Obesity Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- Medicare coverage for continuous glucose monitors
-- CMS removal of administrative red-tape issues for physicians
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on April 19, 2018.
Original Filing: 300949921.xml
Lobbying Issues
-- H.R. 309 / S. 920 - National Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes. Became Public Law No. 115-80: Contact with HHS regarding implementation
-- H.R. 3358 / S. 1771 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; H.R. 1892 - Continuing Resolution; H.R. 1625 - Vehicle for Consolidated Appropriations Act 2018: FY 2018 federal funding for diabetes research and the Centers for Disease Control and Prevention
-- H.R. 849 / S. 260 - Protecting Seniors' Access to Medicare Act of 2017: IPAB repeal
-- H.R. 1898 - To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement
-- H.R. 1953 / S. 830 - Treat and Reduce Obesity Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- Medicare coverage for continuous glucose monitors
-- H.R. 1892 - Continuing Resolution: Changes to the Medicare Access and CHIP Reauthorization Act of 2016 regarding CMS flexibility for cost measures, penalties, Part B drugs, and PTAC
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
Galileo Consulting Group, Inc. amended a lobbying report for representation of American Association of Clinical Endocrinologists in Q42017 on Feb. 14, 2018.
Original Filing: 300940258.xml
Lobbying Issues
-- H.R. 309 / S. 920 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes. Became Public Law No. 115-80: Contact with HHS regarding implementation.
-- H.R. 3358 / S. 1771 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; H.J.Res. 123, H.R. 1370 - Continuing Resolutions: FY 2018 federal funding for diabetes research and the Centers for Disease Control and Prevention.
-- H.R. 849 / S. 260 - Protecting Seniors' Access to Medicare Act of 2017: IPAB repeal.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- Issues regarding red tape and other impediments to practice.
Agencies Lobbied
Health & Human Services - Dept of (HHS)
4th Quarter, 2017
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on Jan. 22, 2018.
Original Filing: 300935715.xml
Lobbying Issues
-- H.R. 309 / S. 920 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
-- H.R. 3358 / S. 1771 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; H.J.Res. 123, H.R. 1370 - Continuing Resolutions: FY 2018 federal funding for diabetes research and the Centers for Disease Control and Prevention.
-- H.R. 849 / S. 260 - Protecting Seniors' Access to Medicare Act of 2017: IPAB repeal.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on Oct. 20, 2017.
Original Filing: 300914100.xml
Lobbying Issues
-- H.R. 309 / S. 920 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
-- H.R. 1628 - American Health Care Act of 2017 / Senate Better Care Reconciliation Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
-- H.R. 3358 / S. 1771 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018: FY 2018 federal funding for diabetes research and the Centers for Disease Control and Prevention.
-- H.R. 849 / S. 260 - Protecting Seniors' Access to Medicare Act of 2017: IPAB repeal.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on July 20, 2017.
Original Filing: 300897700.xml
Lobbying Issues
-- H.R. 309 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
-- H.R. 1628 - American Health Care Act of 2017 / Senate Better Care Reconciliation Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
-- Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; FY 2018 federal funding for diabetes research and the Centers for Disease Control and Prevention.
-- H.R. 849 / S. 260 - Protecting Seniors' Access to Medicare Act of 2017: IPAB repeal.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on April 20, 2017.
Original Filing: 300873720.xml
Lobbying Issues
-- H.R. 309 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
-- H.R. 1628 - American Health Care Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on Jan. 23, 2017.
Original Filing: 300857692.xml
Lobbying Issues
H.R. 1192 / S. 586 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; responses to Centers for Medicare & Medicaid Services requests for information regarding implementation; discussion with Center for Medicare & Medicaid Innovation regarding development of alternative payment models for diabetes.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on Oct. 20, 2016.
Original Filing: 300835842.xml
Lobbying Issues
H.R. 1192 / S. 586 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; responses to Centers for Medicare & Medicaid Services requests for information regarding implementation; discussion with Center for Medicare & Medicaid Innovation regarding development of alternative payment models.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $30,000. The report was filed on July 20, 2016.
Original Filing: 300817924.xml
Lobbying Issues
H.R. 1192 / S. 586 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; comments in response to CMS proposed rule.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on April 19, 2016.
Original Filing: 300795484.xml
Lobbying Issues
H.R. 1192 / S. 586 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Jan. 20, 2016.
Original Filing: 300784463.xml
Lobbying Issues
H.R. 1192 / S. 586 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3940 - Meaningful Use Hardship Relief Act of 2015 / S. 2425 - Patient Access and Medicare Protection Act: Hardship exemptions for meaningful use of electronic health care records.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764317.xml
Lobbying Issues
H.R.1192/S.586 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015: Discussions regarding the resources for quality measures development included in the legislation.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on July 19, 2015.
Original Filing: 300740327.xml
Lobbying Issues
H.R.1192/S.586 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015: Repeal and replace the sustainable growth rate (SGR) with a new payment system.
Participate in Senate Finance Committee Chronic Care Initiative request for proposals.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on April 20, 2015.
Original Filing: 300725475.xml
Lobbying Issues
H.R.1192/S.586 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015: Repeal and replace the sustainable growth rate (SGR) with a new payment system.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Jan. 20, 2015.
Original Filing: 300707640.xml
Lobbying Issues
H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Oct. 20, 2014.
Original Filing: 300683752.xml
Lobbying Issues
H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4015 / S. 2000 / S. 2110 / S. 2122 - SGR Repeal and Medicare Provider Payment Modernization Act of 2014: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on July 20, 2014.
Original Filing: 300663917.xml
Lobbying Issues
H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4015 / S. 2000 / S. 2110 / S. 2122 - SGR Repeal and Medicare Provider Payment Modernization Act of 2014: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
Agencies Lobbied
U.S. Senate
1st Quarter, 2014
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on April 18, 2014.
Original Filing: 300641732.xml
Lobbying Issues
-- H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better
coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 4015 / S. 2000 / S. 2110 / S. 2122: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
-- H.R. 4302 - Protecting Access to Medicare Act of 2014: Legislation to halt Medicare cuts to physician payments for 12 months, until April 1, 2015.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Jan. 22, 2014.
Original Filing: 300628314.xml
Lobbying Issues
-- H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better
coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2810 - Medicare Patient Access and Quality Improvement Act of 2013 / S. __ - Original Bill to Repeal Sustainable Growth Rate System and to Consider Health Care Extenders: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.-- Senate Amendment to H.J. Res. 59 - Bipartisan Budget Act of 2013 and Pathway to SGR Reform Act of 2013: Legislation to address the SGR until March 31, 2014.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Oct. 19, 2013.
Original Filing: 300601122.xml
Lobbying Issues
-- H.R. 1074/S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and
Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better
coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Communications with relevant congressional committees regarding discussion drafts for legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
-- Communications with Centers for Medicare and Medicaid Services (CMS) regarding CY 2014 Medicare Physician Fee Schedule proposal to cut ultrasound guidance procedure, CPT code 76942.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on July 22, 2013.
Original Filing: 300586275.xml
Lobbying Issues
-- H.R. 1074/S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and
Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better
coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Communications with relevant congressional committees regarding discussion drafts for legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment, and the future of Medicare Physician Payment.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on April 22, 2013.
Original Filing: 300564248.xml
Lobbying Issues
-- H.R. 1074/S. 539 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and
Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better
coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Examine solutions for Medicare system of reimbursement for physicians, including repeal of sustainable growth rate (SGR) and reform of physician payment.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Jan. 22, 2013.
Original Filing: 300542774.xml
Lobbying Issues
-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and
Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better
coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.-- H.R. 2104 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 / S.
3338 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2012:
Legislation to amend the Public Health Service Act to require personnel who perform or plan the technical component of either
medical imaging examinations or radiation therapy procedures for medical purposes to possess certain certification or
licensure, effective January 1, 2014, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2020 / S. 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011: Legislation to set
payment rates for physicians for dual-energy x-ray absorptiometry (DXA) screening tests at 70 percent of the 2006 rate for 2012
and 2013.
-- H.R. 8 - American Taxpayer Relief Act of 2012: Medicare phyisican payment for 2013.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Oct. 22, 2012.
Original Filing: 300520928.xml
Lobbying Issues
-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
-- H.R. 2104 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 / S. 3338 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2012: Legislation to amend the Public Health Service Act to require personnel who perform or plan the technical component of either medical imaging examinations or radiation therapy procedures for medical purposes to possess certain certification or licensure, effective January 1, 2014, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2020 / S. 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011: Legislation to set payment rates for physicians for dual-energy x-ray absorptiometry (DXA) screening tests at 70 percent of the 2006 rate for 2012 and 2013.
-- Medicare phyisican payment for 2013.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on July 20, 2012.
Original Filing: 300494143.xml
Lobbying Issues
-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
-- H.R. 2104 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 / S. 3338 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2012: Legislation to amend the Public Health Service Act to require personnel who perform or plan the technical component of either medical imgaing examinations or radiation therapy procedures for medical purposes to possess certain certification or licensure, effective January 1, 2014, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2020 / S. 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011: Legislation to set payment rates for physicians for dual-energy x-ray absorptiometry (DXA) screening tests at 70 percent of the 2006 rate for 2012 and 2013.
-- Medicare phyisican payment for 2013.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on April 20, 2012.
Original Filing: 300470407.xml
Lobbying Issues
-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2020/S. 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011: Legislation to set payment rates for physicians for dual-energy x-ray absorptiometry (DXA) screening tests at 70 percent of the 2006 rate for 2012 and 2013.
-- H.R. 3630 - Middle Class Tax Relief and Job Creation Act of 2012: Examine two-month payment freeze for dual energy X-ray absorptiometry (DXA) screening and Medicare physician payment for remainder of 2012.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Jan. 20, 2012.
Original Filing: 300449877.xml
Lobbying Issues
-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2020/S. 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011: Legislation to set payment rates for physicians for dual-energy x-ray absorptiometry (DXA) screening tests at 70 percent of the 2006 rate for 2012 and 2013.
-- H.R. 3630 - Temporary Payroll Tax Cut Continuation Act of 2011: Examine two-month payment freeze for dual energy X-ray absorptiometry (DXA) screening and Medicare physician payment.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Oct. 20, 2011.
Original Filing: 300429474.xml
Lobbying Issues
-- H.R. 2960 - National Diabetes Clinical Care Commission Act: Legislation to establish within the Department of Health and Human Services (HHS) a National Diabetes Clinical Care Commission to evaluate and make recommendations regarding better coordination and leveraging of federal programs that support appropriate clinical care for those with pre-diabetes and diabetes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2020/S. 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011: Legislation to set payment rates for physicians for dual-energy x-ray absorptiometry (DXA) screening tests at 70 percent of the 2006 rate for 2012 and 2013.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on July 20, 2011.
Original Filing: 300404997.xml
Lobbying Issues
-- Diabetes initiative: New federal commission on clinical care for people with diabetes, Medicare care management programs and programs for physician education and training.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2020/S. 1096 - Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011: Legislation to set payment rates for physicians for dual-energy x-ray absorptiometry (DXA) screening tests at 70 percent of the 2006 rate for 2012 and 2013.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on April 20, 2011.
Original Filing: 300379609.xml
Lobbying Issues
-- Diabetes initiative: New federal council on clinical care for people with diabetes, Medicare care management programs and programs for physician education and training.
-- Support obesity initiatives and nutrition programs/policy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Reintroduction in the 112th Congress of legislation (as yet unnumbered) to revise the Medicare reimbursement for bone densitometry scans to screen and set a diagnosis baseline for osteoporosis.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Jan. 20, 2011.
Original Filing: 300353772.xml
Lobbying Issues
-- Diabetes initiative: New federal council on clinical care for people with diabetes, Medicare care management programs and programs for physician education and training.
-- Support obesity initiatives and nutrition programs/policy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 4994, Medicare and Medicaid Extenders Act of 2010: Medicare physician payment rates starting January 1, 2011, halting the cut of 25 percent.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Oct. 20, 2010.
Original Filing: 300328269.xml
Lobbying Issues
-- Diabetes initiative: New federal council on clinical care for people with diabetes, Medicare care management programs and programs for physician education and training
-- Support obesity initiatives and nutrition programs/policy
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 3590, Patient Protection and Affordable Care Act: Support implementation of Medicare Fracture Prevention and Osteoporosis Testing Act of 2009, including dual energy x-ray absorptiometry (DXA) Medicare reimbursement for 2010-2011 at 70 percent of 2006 level-- H.R 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010: Support 2.2 percent update to 2010 physician fee schedule for June 1 - November 30, 2010 period of service
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on July 20, 2010.
Original Filing: 300298787.xml
Lobbying Issues
-- Diabetes iniative: Support new federal council on clinical care for people with diabetes, Medicare care management programs and programs for physician education and training
-- Support obesity initiatives and nutrition programs/policy
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 3590, Patient Protection and Affordable Care Act: Support implementation of Medicare Fracture Prevention and Osteoporosis Testing Act of 2009, including dual energy x-ray absorptiometry (DXA) Medicare reimbursement for 2010-2011 at 70 percent of 2006 level
-- H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010: Support 2.2 percent update to 2010 physician fee schedule for June 1 - November 30, 2010 period of service
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on April 20, 2010.
Original Filing: 300273565.xml
Lobbying Issues
-- H.R. 3590, Patient Protection and Affordable Care Act: Incorporate modified S. 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009, with DXA reimbursement for 2010-2011 at 70% of 2006 Medicare reimbursement; oppose Independent Medicare Commission; oppose budget neutral shift from all other services for primary care bonus; support Medical Liability Reform Demonstrations; preserve reimbursement for ultrasound services; prevention and education programs for diabetes-- Diabetes Initiative: Support legislative proposal for a new federal council on clinical care for diabetes patients, Medicare care management programs and programs for physician education and training
-- Explore Obesity Initiatives and Medicare payments
-- Support patches to delay cuts to Medicare physician payments
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Jan. 20, 2010.
Original Filing: 300244964.xml
Lobbying Issues
-- HR 3962 - Affordable Health Care for America Act (and predecessor, HR 3200): Work to incorporate a modification of HR 1894/S 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009, with DXA reimbursement for 2010 and 2011 at 70% of 2006 level of Medicare reimbursement; preserve Medicare reimbursement for ultrasound services; oppose Independent Medicare Commission in Senate health care reform bill; support prevention and education programs relating to diabetes care-- HR 3961 - Medicare Physician Payment Reform Act of 2009: Support repeal of current formula for physician payment and replace with new system
-- HR 3590 - Patient Protection and Affordable Care Act: Work to incorporate a modification of S 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009, with DXA reimbursement for 2010 and 2011 at 70% of 2006 level of Medicare reimbursement; oppose Independent Medicare Commission; oppose budget neutral shift from all other services to pay for primary care bonus; support Medical Liability Reform Demonstrations; preserve reimbursement for ultrasound services; support prevention and education programs relating to diabetes care
-- S 1776 - Medicare Physician Fairness Act of 2009: Repeal current Medicare physician payment system
-- Diabetes Initiative: Prepare draft provisions for new federal council on clinical care for people with diabetes, including Medicare care management programs and programs for physician education and training
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on Oct. 20, 2009.
Original Filing: 300221599.xml
Lobbying Issues
-- HR 1894 / S 769 (Medicare Fracture Prevention and Osteoporosis Testing Act of 2009) -- Legislation to ensure patient access to osteoporosis testing, prevention and treatment services by restoring adequate Medicare payments for these services.
-- HR 3200 / previous discussion draft (America's Affordable Health Choices Act) -- Section on prevention, incorporating HR 1894 or abbreviated language where the Medicare payment relief would be for 2010 and 2011 at 75 percent of the 2006 reimbursement rate, ensuring that ultrasound practice expense equipment utilization rate is not cut in the final HR 3200 and Medicare physician reimbursement.
-- America's Healthy Future Act / previous Finance Committee health care reform discussion papers -- Section on prevention, incorporating S 769 or abbreviated language where the Medicare payment relief would be for 2010 and 2011 at 70 percent of the 2006 reimbursement rate, ensuring that ultrasound practice expense equipment utilization rate is not cut and Medicare physician reimbursement.
-- Diabetes Initiative -- Assisted in preparing legislative specifications for a new federal council on clinical care for people with diabetes, Medicare care management programs and programs for physician education and training.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $20,000. The report was filed on July 20, 2009.
Original Filing: 300193855.xml
Lobbying Issues
-- HR 1894/S 769: Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 - Legislation to ensure patient access to osteoporosis testing, prevention and treatment services by restoring adequate Medicare payments for these services.
-- HR 3200: America's Affordable Health Choices Act of 2009 and its previous discussion draft - Section on prevention, incorporate HR 1894 or similar language so that the Medicare payment relief for 2010-2011 would be 75 percent of the 2006 reimbursement rate, ensure that ultrasound practice expense equipment utilization rate is not cut in the final HR 3200, and Medicare physician reimbursement.
-- Senate health care reform discussion papers - Section on prevention, incorporate S 769 or similar language so that the Medicare payment relief for 2010-2011 would be 75 percent of the 2006 reimbursement rate, ensure that ultrasound practice expense equipment utilization rate is not cut, and Medicare physician reimbursement.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, Galileo Consulting Group, Inc. lobbied for American Association of Clinical Endocrinologists , earning $10,000. The report was filed on April 20, 2009.
Original Filing: 300162835.xml
Lobbying Issues
H.R. 1894 / S. 769 (Medicare Fracture Prevention and Osteoporosis Testing Act of 2009) -- Legislation to ensure patient access to osteoporosis testing, prevention and treatment service by restoring adequate Medicare payments for these services.
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...